Uncertainty Looms After Hexo Reports Decent Earnings

Here’s why investors seem to be hesitant with Hexo (TSX:HEXO)(NYSE:HEXO) right now.

| More on:

Hexo (TSX:HEXO)(NYSE:HEXO) is a company I think remains a great play on the domestic Canadian cannabis market. Hexo’s recently reported decent earnings, and investors may be excited about its existing business.

However, its recent acquisitions paint a different picture.

It now appears this company is trying to push to become a global player. As it is currently still a relatively small player in the global cannabis space, this is a good thing. There’s a race to the top, and Hexo seems willing to look at expanding in prudent ways.

That said, this space is a volatile one. Accordingly, it appears some investors feel there’s too much uncertainty with this stock right now.

Hexo’s decent earnings call is worth a second look

Hexo’s recent earnings certainly provide investors with what looks like pretty decent long-term upside. The company reported total net revenue of $32.9 million this past quarter. This was up from $17 million from the prior-year quarter.

That’s some decent revenue growth.

Additionally, this past quarter marked the seventh consecutive quarter where the firm reported positive adjusted EBITDA. Not only that, but the firm also noted that non-beverage adult-use revenue increase by 6% amid growing beverage-based adult-use sales.

Net revenue of adult-use cannabis products also marked the fifth consecutive quarter of improvement. This has helped Hexo to maintain the lead market share position in Quebec’s cannabis market. Revenue for the rest of Canada increased by 49%, signaling the company isn’t just a tiny regional player any more.

These earnings are a testament to this company’s long-term potential. Indeed, investors will continue to be looking at the company’s high-margin products to see how profitable Hexo will be long term.

Foreign growth a key for investors

While the earnings call paints a promising picture, investors seem to be worried about the company’s global expansion potential. Hexo still isn’t a company with direct access to the U.S. market like other Canadian-listed peers. Additionally, despite impressive revenue growth, this firm’s financial position leaves something more to desire.

As of a month ago, Hexo had no real presence in the U.S. market. The firm has heavily focused on improving its foothold in the domestic market and is just starting to build its foreign brand strategy.

Hexo has placed its bets on Charles Bowman, who was recently inducted as the general manager of U.S. operations, and Rose Marie Gage, chair of director board. They are supposed to contribute with their extensive experience in operations to improve Hexo’s market presence in the U.S.

However, until more progress is made, many investors may continue to sit on the sidelines.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Chris MacDonald has no position in any of the stocks mentioned. The Motley Fool recommends HEXO. and HEXO.

More on Cannabis Stocks

space ship model takes off
Cannabis Stocks

2 Canadian Stocks With Strong Momentum for 2025

Celestica Inc. (TSX:CLS) stock and Dollarama (TSX:DOL) stock have sustained strong price growth momentum for a long time.  Here’s why…

Read more »

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Pot Stocks: Buy, Sell, or Hold in 2025?

Cannabis stocks remain a bit risky, but could long-term investors be in for more pain or far more profits?

Read more »

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

Could the Cannabis Bubble Re-Inflate?

Let's dive into the question of whether the Canadian cannabis bubble can re-inflate from here.

Read more »

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

Should You Buy Canopy Growth Stock or Green Thumb Stock Today?

Let's dive into two cannabis giants, and which one may be the better pick for long-term investors.

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Could Aurora Cannabis Stock Finally Recover by Year-End?

Down 99% from all-time highs, Aurora Cannabis stock is focused on improving profit margins and expanding sales of its medical…

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Are Pot Stocks About to Surge Again? 

With pot stocks making big moves of late, many investors are now asking whether the cannabis sector is worth investing…

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Can Pot Stocks Aurora Cannabis and Canopy Growth Bounce Back in Q4?

Down over 99% from all-time highs, Canadian pot stocks such as Aurora Cannabis and Canopy Growth remain high-risk bets.

Read more »

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Can Canopy Growth Stock Finally Recover in 2024?

Down 98% from all-time highs, Canopy Growth remains a high-risk investment in 2024 given its weak fundamentals.

Read more »